MyFinsight
Home
Blog
About
Short-term investments
$148,831K
Cash and cash
equivalents
$49,629K
(-53.24%↓ Y/Y)
Prepaid expenses and
other current assets
$4,643K
(215.42%↑ Y/Y)
Property and equipment,
at cost
$241K
(29.57%↑ Y/Y)
Total current assets
$203,103K
(88.73%↑ Y/Y)
Other assets
$2,550K
(4373.68%↑ Y/Y)
Property and equipment,
net
$90K
(-18.18%↓ Y/Y)
Less accumulated
depreciation
$151K
(98.68%↑ Y/Y)
Total assets
$205,743K
(90.89%↑ Y/Y)
Total liabilities and
stockholders' equity
$205,743K
(90.89%↑ Y/Y)
Total stockholders
equity
$183,794K
(86.38%↑ Y/Y)
Total liabilities
$21,949K
Accumulated deficit
-$268,840K
(-48.61%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$54K
Additional paid-in capital
$452,667K
(61.95%↑ Y/Y)
Total current
liabilities
$20,289K
(121.25%↑ Y/Y)
Other liabilities
$1,660K
Common stock, 0.001 par
value 200,000,000...
$21K
(75.00%↑ Y/Y)
Accounts payable
$14,010K
(164.29%↑ Y/Y)
Accrued liabilities
$6,279K
(62.29%↑ Y/Y)
Back
Back
Balance Sheet
Forte Biosciences, Inc. (FBRX)
Forte Biosciences, Inc. (FBRX)
source: myfinsight.com